Additionally, in human gliomas, a heterogeneous group of primary malignant brain tumours with strong resistance to chemotherapy and radiotherapy, the reduction of TRIM8 expression, correlates with high levels of miRNA-17-5p, leading to an unfavourable clinical outcome of the patients. Here, TRIM8 is linked to brain neoplasm.